Gene therapy meets vaccine development
- 1 December 2004
- journal article
- Published by Elsevier in Trends in Biotechnology
- Vol. 22 (12) , 623-626
- https://doi.org/10.1016/j.tibtech.2004.10.006
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrenceInternational Journal of Cancer, 2004
- Modification to the Capsid of the Adenovirus Vector That Enhances Dendritic Cell Infection and Transgene-Specific Cellular Immune ResponsesJournal of Virology, 2004
- The Maturation of Murine Dendritic Cells Induced by Human Adenovirus Is Mediated by the Fiber Knob DomainPublished by Elsevier ,2003
- Dendritic cells transduced with TAT protein transduction domain-containing tyrosinase-related protein 2 vaccinate against murine melanomaEuropean Journal of Immunology, 2003
- Lentiviral vectors containing the human immunodeficiency virus type-1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen-presenting cells in vivoBlood, 2002
- Rapid Induction of Tumor-specific Type 1 T Helper Cells in Metastatic Melanoma Patients by Vaccination with Mature, Cryopreserved, Peptide-loaded Monocyte-derived Dendritic CellsThe Journal of Experimental Medicine, 2002
- Visualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivoNature Immunology, 2002
- Dendritic Cells Transduced with HSV-1 Amplicons Expressing Prostate-Specific Antigen Generate Antitumor Immunity in MiceHuman Gene Therapy, 2001
- A Novel Recombinant Adeno-Associated Virus Vaccine Induces a Long-Term Humoral Immune Response to Human Immunodeficiency VirusHuman Gene Therapy, 2001
- MHC class II presentation of endogenously expressed antigens by transfected dendritic cellsGene Therapy, 2001